ATC Group: C01CE Phosphodiesterase inhibitors

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C01CE in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C01 Cardiac therapy
3 C01C Cardiac stimulants excl. cardiac glycosides
4 C01CE Phosphodiesterase inhibitors

Group C01CE contents

Code Title
C01CE01 Amrinone
C01CE02 Milrinone
C01CE03 Enoximone
C01CE04 Bucladesine

Active ingredients in C01CE

Active Ingredient

Enoximone, an imidazolone, has both positive inotropic and vasolidator properties, inhibiting cardiac phosphodiesterase III with an increase in cAMP.

Milrinone is a positive inotrope and vasodilator, with little chronotropic activity. It also improves left ventricular diastolic relaxation. It is a selective inhibitor of peak III phosphodiesterase isoenzyme in cardiac and vascular muscle. It produces slight enhancement of A-V node conduction, but no other significant electrophysiological effects.

Related product monographs

Document Type Information Source  
 PERFAN Concentrate for solution for injection or infusion MPI, EU: SmPC Health Products Regulatory Authority (IE)
 PRIMACOR Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)